Gabelli Funds’s NEVRO CORP. NVRO Stock Holding History

Gabelli Funds’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,322,950	Closed	-$7.73M	–	1275
2025 Q1	$7.73M	Buy	+1,322,950	New	+$6.97M	0.06%	345
2022 Q2	–	Sell	-4,000	Closed	-$289K	–	1426
2022 Q1	$289K	Buy	+4,000	New	+$288K	﹤0.01%	1167
2019 Q3	–	Sell	-107,000	Closed	-$6.94M	–	1145
2019 Q2	$6.94M	Sell	107,000 -35,500	-25%	-$2.21M	0.04%	431
2019 Q1	$8.91M	Sell	142,500 -15,000	-10%	-$705K	0.06%	388
2018 Q4	$6.13M	Buy	157,500 +12,000	+8%	+$533K	0.04%	439
2018 Q3	$8.29M	Buy	145,500 +100,298	+222%	+$6.27M	0.05%	428
2018 Q2	$3.61M	Buy	45,202 +25,702	+132%	+$2.13M	0.02%	648
2018 Q1	$1.69M	Sell	19,500 -3,000	-13%	-$242K	0.01%	818
2017 Q4	$1.55M	Buy	+22,500	New	+$1.8M	0.01%	830

Other funds holding NVRO

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Gabelli Funds's NVRO Position: Q2 2025 in Review

Gabelli Funds sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 1,322,950 shares — an estimated $7.73M sold.

Gabelli Funds first reported a position in NVRO in Q4 2017 and held it in 9 quarters. The position peaked at $8.91M in Q1 2019. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.

Gabelli Funds reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
Gabelli Funds sold 1,322,950 NEVRO CORP. shares in Q2 2025, an estimated $7.73M.
Gabelli Funds first reported a position in NEVRO CORP. in Q4 2017 and held it in 9 quarters.
Gabelli Funds's NEVRO CORP. position peaked at $8.91M in Q1 2019.
1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.

Based on Gabelli Funds's 13F filing for Q2 2025, filed 13 Aug 2025.